Histological and Immunohistochemical Characteristics for Hereditary Breast Cancer Risk in a Cohort of Brazilian Women

• Published in: Revista Brasileira de ginecologia e obstetrícia 2022-08, Vol.44 (8), p.761-770
• Main Authors: de Freitas, Renata Mendes, Guerra, Maximiliano Ribeiro, Fayer, Vívian Assis, Campos, Angélica Atala Lombelo, Cintra, Jane Rocha Duarte, Warren, Joan, Ervilha, Rafaela Russi, de Paula, Camila Damasceno, Bustamante-Teixeira, Maria Teresa
• Format: Article
• Language: English
• Subjects: Brazil - epidemiology; breast cancer; Breast Neoplasms - epidemiology; Breast Neoplasms - genetics; Breast Neoplasms - pathology; cohort studies; Female; genetic counseling; Genetic Predisposition to Disease; hereditary breast and ovarian cancer syndrome; Humans; immunohistochemistry; OBSTETRICS & GYNECOLOGY; Original; Ovarian Neoplasms - genetics; Retrospective Studies
• ISSN: 0100-7203; 1806-9339; 1806-9339
• DOI: 10.1055/s-0042-1743103

The study aimed to characterize the clinical, histological, and immunohistochemical profile of women with invasive breast cancer, according to the risk for Hereditary Predisposition Breast and Ovarian Cancer Syndrome in a Brazilian population.  This is a retrospective study performed from a hospital-based cohort of 522 women, diagnosed with breast cancer treated at an oncology referral center in the Southeast region of Brazil, between 2014 and 2016.  Among the 430 women diagnosed with invasive breast cancer who composed the study population, 127 (29.5%) were classified as at increased risk for hereditary predisposition to breast and ovarian cancer syndrome. There was a lower level of education in patients at increased risk (34.6%) when compared with those at usual risk (46.0%). Regarding tumor characteristics, women at increased risk had higher percentages of the disease diagnosed at an advanced stage (32.3%), and with tumors > 2cm (63.0%), with increased prevalence for both characteristics, when compared with those at usual risk. Furthermore, we found higher percentages of HG3 (43.3%) and K -67 ≥ 25% (64.6%) in women at increased risk, with prevalence being about twice as high in this group. The presence of triple-negative tumors was observed as 25.2% in women at increased risk and 6.0% in women at usual risk, with the prevalence of absence of biomarkers being 2.5 times higher among women in the increased risk group.  From the clinical criteria routinely used in the diagnosis of breast cancer, the care practice of genetic counseling for patients at increased risk of hereditary breast cancer in contexts such as Brazil is still scarce.